Via TÜV SÜD
“The COVID-19 pandemic is evolving daily, with effects going far beyond the directly affected areas with outbreaks. During this time, the safety and well-being of our colleagues and clients is our highest priority. Through our contingency plans, TÜV SÜD is committed to minimising the impact to all clients while considering the relevant local situation and public health safety guidelines. Where possible, we seek your collaboration in keeping to your scheduled project dates to avoid any impact to your certification status or existing project timelines.”
“To support the fight against the coronavirus, TÜV SÜD is prioritising all medical device and in-vitro diagnostic device projects that are related to the treatment, testing, and monitoring of the coronavirus outbreak.”
See all the ways TÜV SÜD is helping their partners through this chaotic time.
MAA COVID-19 INFORMATION DISCLAIMER:
The Medical Alley Association is providing COVID-19 related information, including the “COVID-19 Resource Connect” feature on its website and summaries of laws, executive orders, and government programs that may be of interest to members, as a public service. The Medical Alley Association makes no representations, guarantees, or warranties as to the accuracy, completeness, currency, or suitability of the COVID-19 related information provided by the Medical Alley Association on its website, in newsletters, or in any other communications. The Medical Alley Association specifically disclaims any and all liability for any claims or damages that may result from providing COVID-19 related information online or in other communications or linking to third party websites or other sources of information. The Medical Alley Association makes no effort to independently verify, and does not exert editorial control over, information provided by third parties.
The Medical Alley Association does not endorse any of the products, vendors, consultants, or documentation referenced in, or connected to parties through, the COVID-19 Resource Connect feature or via email or other communications.
